Dasatinib Sandoz 100 mg, Filmtabletten - 30 Swissmedic Key 67368005 Registration Holder Sandoz Pharmaceuticals AG Name Dasatinib Sandoz 100 mg, Filmtabletten Date of registration 08.10.2020 Original/Generic Generic Introduction of Sequence 08.10.2020 ATC-Classification Dasatinib (L01EA02) Revision date WHO WHO-DDD Valid until Index Therapeuticus (BSV) 07.16.10. Show package size 30 Index Therapeuticus (Swissmedic) 07.16.10. Description Swissmedic categorie. A SL Eintrag Yes Indication Information for professionals IP Consumer information Ex-factory-Price 1102.52 Limitation Yes Limitation text
Deductible 10 % Consumer price 1215.45 Feedback FB Daily cost GTIN 7680673680056 Medication Code Synthetika Pharmacode Disponibility
Composition dasatinibum 100 mg, cellulosum microcristallinum, lactosum monohydricum 138 mg, carmellosum natricum conexum, hydroxypropylcellulosum, magnesii stearas, Überzug: poly(alcohol vinylicus), E 171, talcum, glyceroli monopalmitostearas, natrii laurilsulfas, pro compresso obducto corresp. natrium 2.912 mg. Packungsbestandteile Galenic Form Coated tablets Active Agent Dose Dasatinib 100 mg
BAG: Active Agent Dose Dasatinib 100 mg
Inactive agents Dose additional_information Carmellosum Natricum Conexum Cellulosum Microcristallinum E 171 color. Glyceroli Monopalmitostearas Hydroxypropylcellulosum Lactose Monohydrate 138 mg Magnesii Stearas Natrii Laurilsulfas Poly(Alcohol Vinylicus) Überzug Pro Compresso Obducto Talcum
Source Data was imported : 07.02.2025
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
